NDRG2
Basic information
Region (hg38): 14:21016763-21070872
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the NDRG2 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 1 | |||||
missense | 15 | 17 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 1 | 1 | ||||
non coding | 0 | |||||
Total | 0 | 0 | 15 | 1 | 2 |
Variants in NDRG2
This is a list of pathogenic ClinVar variants found in the NDRG2 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
14-21017625-G-A | not specified | Uncertain significance (Sep 17, 2021) | ||
14-21017625-G-T | not specified | Uncertain significance (Apr 23, 2024) | ||
14-21017636-G-A | not specified | Uncertain significance (Feb 05, 2024) | ||
14-21017687-T-C | not specified | Uncertain significance (Aug 14, 2024) | ||
14-21018034-C-T | not specified | Uncertain significance (Jul 14, 2021) | ||
14-21018512-A-G | Benign (Mar 01, 2018) | |||
14-21018786-G-T | not specified | Uncertain significance (Nov 19, 2024) | ||
14-21019117-T-C | not specified | Uncertain significance (May 26, 2022) | ||
14-21019138-G-A | not specified | Uncertain significance (Mar 31, 2024) | ||
14-21019158-C-A | not specified | Uncertain significance (Jan 24, 2024) | ||
14-21019687-T-C | not specified | Uncertain significance (Nov 07, 2022) | ||
14-21019696-A-G | not specified | Uncertain significance (Jul 02, 2024) | ||
14-21019700-T-G | not specified | Uncertain significance (Jun 27, 2022) | ||
14-21019714-A-G | not specified | Uncertain significance (Jan 10, 2023) | ||
14-21019720-T-C | not specified | Uncertain significance (May 06, 2024) | ||
14-21020500-T-C | not specified | Uncertain significance (May 24, 2023) | ||
14-21020798-G-C | not specified | Uncertain significance (Oct 20, 2023) | ||
14-21020837-T-C | not specified | Uncertain significance (Jul 12, 2023) | ||
14-21021833-C-T | not specified | Likely benign (Aug 16, 2021) | ||
14-21021844-A-G | not specified | Uncertain significance (Sep 10, 2024) | ||
14-21022081-C-G | not specified | Uncertain significance (Oct 29, 2024) | ||
14-21022102-C-A | not specified | Uncertain significance (Sep 18, 2023) | ||
14-21022150-C-T | not specified | Uncertain significance (May 10, 2024) | ||
14-21022423-C-A | Benign (May 04, 2018) | |||
14-21022431-G-A | not specified | Uncertain significance (Oct 08, 2024) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
NDRG2 | protein_coding | protein_coding | ENST00000556147 | 15 | 54110 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.0000220 | 0.996 | 125730 | 0 | 18 | 125748 | 0.0000716 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.621 | 192 | 218 | 0.882 | 0.0000122 | 2387 |
Missense in Polyphen | 69 | 99.26 | 0.69515 | 1030 | ||
Synonymous | -0.296 | 89 | 85.5 | 1.04 | 0.00000508 | 737 |
Loss of Function | 2.52 | 12 | 25.8 | 0.465 | 0.00000126 | 288 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.0000906 | 0.0000905 |
Ashkenazi Jewish | 0.0000997 | 0.0000992 |
East Asian | 0.0000589 | 0.0000544 |
Finnish | 0.000139 | 0.000139 |
European (Non-Finnish) | 0.0000882 | 0.0000879 |
Middle Eastern | 0.0000589 | 0.0000544 |
South Asian | 0.0000329 | 0.0000327 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Contributes to the regulation of the Wnt signaling pathway. Down-regulates CTNNB1-mediated transcriptional activation of target genes, such as CCND1, and may thereby act as tumor suppressor. May be involved in dendritic cell and neuron differentiation. {ECO:0000269|PubMed:12845671, ECO:0000269|PubMed:16103061, ECO:0000269|PubMed:21247902}.;
- Pathway
- Validated targets of C-MYC transcriptional repression
(Consensus)
Recessive Scores
- pRec
- 0.103
Intolerance Scores
- loftool
- 0.743
- rvis_EVS
- 0.04
- rvis_percentile_EVS
- 57.15
Haploinsufficiency Scores
- pHI
- 0.154
- hipred
- N
- hipred_score
- 0.480
- ghis
- 0.506
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.192
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Ndrg2
- Phenotype
- integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); homeostasis/metabolism phenotype; cellular phenotype; skeleton phenotype; hematopoietic system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); neoplasm; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); immune system phenotype;
Gene ontology
- Biological process
- negative regulation of cytokine production;signal transduction;regulation of vascular endothelial growth factor production;Wnt signaling pathway;substantia nigra development;cell differentiation;negative regulation of smooth muscle cell proliferation;negative regulation of ERK1 and ERK2 cascade;regulation of platelet-derived growth factor production
- Cellular component
- nucleus;cytoplasm;Golgi apparatus;cytosol;growth cone;perinuclear region of cytoplasm;extracellular exosome
- Molecular function
- molecular_function;protein binding